Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer

NCT00912275 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00912275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00912275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
November 24, 2008
Completion date
July 7, 2017
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer